HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paola Chiarugi Selected Research

NVP-AST487

12/2016Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paola Chiarugi Research Topics

Disease

70Neoplasms (Cancer)
01/2022 - 11/2002
19Prostatic Neoplasms (Prostate Cancer)
01/2022 - 04/2009
16Melanoma (Melanoma, Malignant)
01/2019 - 03/2009
10Neoplasm Metastasis (Metastasis)
01/2017 - 07/2007
10Carcinoma (Carcinomatosis)
06/2013 - 11/2002
9Hypoxia (Hypoxemia)
06/2020 - 08/2007
6Carcinogenesis
01/2018 - 08/2007
4Breast Neoplasms (Breast Cancer)
10/2020 - 03/2016
3Inflammation (Inflammations)
01/2012 - 02/2010
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 05/2004
2Osteoporosis
01/2019 - 01/2017
2Colonic Neoplasms (Colon Cancer)
12/2015 - 02/2011
1Pathologic Processes
12/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
06/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Osteolysis
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2017
1Pain (Aches)
01/2017

Drug/Important Bio-Agent (IBA)

11Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 08/2005
9Lactic Acid (Lactate)FDA LinkGeneric
01/2022 - 10/2012
9Phosphotransferases (Kinase)IBA
12/2018 - 10/2005
9CytokinesIBA
01/2018 - 10/2008
6Pharmaceutical PreparationsIBA
10/2020 - 04/2014
6Glucose (Dextrose)FDA LinkGeneric
10/2020 - 10/2012
6Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2013
5EnzymesIBA
12/2021 - 04/2006
5AntioxidantsIBA
01/2020 - 08/2005
5Biomarkers (Surrogate Marker)IBA
01/2019 - 11/2013
5IntegrinsIBA
05/2014 - 10/2008
5Oxidants (Oxidizing Agents)IBA
05/2014 - 08/2005
4MicroRNAs (MicroRNA)IBA
12/2021 - 03/2014
4Estrogen ReceptorsIBA
10/2020 - 03/2016
4Adrenergic Receptors (Adrenergic Receptor)IBA
01/2019 - 03/2013
3LigandsIBA
12/2021 - 10/2005
3Estrogens (Estrogen)FDA Link
10/2020 - 03/2016
3CatecholaminesIBA
01/2019 - 03/2013
3LipidsIBA
01/2018 - 10/2014
3Carbonic Anhydrase IXIBA
11/2017 - 06/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2016 - 01/2012
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2015 - 03/2013
3Interleukin-6 (Interleukin 6)IBA
10/2015 - 09/2010
3Tyrosine (L-Tyrosine)FDA Link
09/2015 - 05/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2014 - 10/2008
3Metalloproteases (Metalloproteinases)IBA
03/2013 - 09/2010
3EphrinsIBA
07/2007 - 10/2005
2EndocannabinoidsIBA
12/2021 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2020 - 06/2016
2Biological ProductsIBA
01/2020 - 03/2013
2Waste Products (Waste Product)IBA
01/2020 - 01/2019
2Zoledronic Acid (Zometa)FDA Link
01/2019 - 01/2017
2LactonesIBA
01/2018 - 05/2013
2Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2018 - 01/2018
2Pyruvic Acid (Pyruvate)IBA
01/2018 - 11/2013
2Aromatase InhibitorsIBA
12/2016 - 03/2016
2Transcription Factors (Transcription Factor)IBA
09/2016 - 11/2013
2Etoposide (VP 16)FDA LinkGeneric
08/2016 - 01/2012
2Oxygen (Dioxygen)IBA
01/2016 - 03/2014
2src-Family KinasesIBA
05/2014 - 08/2010
2Growth Factor ReceptorsIBA
12/2013 - 06/2010
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013 - 12/2012
2Monomeric GTP-Binding ProteinsIBA
09/2010 - 01/2007
2GTP Phosphohydrolases (GTPases)IBA
09/2010 - 04/2009
2Eph Family Receptors (Eph Receptors)IBA
07/2007 - 01/2007
2beta CateninIBA
05/2004 - 11/2002
1Metformin (Glucophage)FDA LinkGeneric
01/2021
1palbociclibIBA
10/2020
1human ERBB2 proteinIBA
10/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
06/2020
13- (2- ethylphenoxy)- 1- (1,2,3,4- tetrahydronaphth- 1- ylamino)- 2- propanol oxalateIBA
06/2020
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2020
1CannabinoidsIBA
01/2020
1Mesylates (Mesylate)IBA
01/2020
1Lysine (L-Lysine)FDA Link
01/2020
1Histones (Histone)IBA
01/2020
1Calcibiotic Root Canal SealerIBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
01/2019
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2019
1Diphosphonates (Bisphosphonates)IBA
01/2019
1Aspartic Acid (Aspartate)FDA Link
01/2019
1NAD (NADH)IBA
01/2019
1Amino AcidsFDA Link
01/2019
1tyrosine receptor (receptor, tyrosine)IBA
12/2018
1Tyrosine Kinase InhibitorsIBA
12/2018
1Oxidoreductases (Dehydrogenase)IBA
01/2018
1Uncoupling Protein 2IBA
01/2018
1Pyruvate Dehydrogenase (Lipoamide)-Phosphatase (Pyruvate Dehydrogenase Phosphatase)IBA
01/2018
1Carbon Nanotubes (Carbon Nanotube)IBA
01/2018
1Analgesics (Analgesic Drugs)IBA
11/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2017
1tramiprosateIBA
11/2017
1NVP-BBT594IBA
12/2016
1Aromatase (CYP19)IBA
12/2016
1Letrozole (Femara)FDA LinkGeneric
12/2016
1Proto-Oncogene Proteins c-retIBA
12/2016
1NVP-AST487IBA
12/2016

Therapy/Procedure

20Therapeutics
10/2020 - 03/2009
3Drug Therapy (Chemotherapy)
01/2020 - 01/2012
1Castration
01/2022